ArticleAdvances in therapy2024

Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities.

Wang-Da Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.